Over 90 Total Lots Up For Auction at One Location - WA 04/08

Xenex inks Japanese distribution deal with Terumo for LightStrike Germ-Zapping Robots

Press releases may be edited for formatting or style | January 05, 2017 Business Affairs Infection Control

"Like Xenex, Terumo was founded by scientists and has been a leader in helping hospitals reduce their infection rates for many years. They share our passion for patient safety and we are very proud to partner with them to provide our LightStrike Germ-Zapping Robot technology to hospitals in Japan," said Joseph Authement, Senior Vice President of Global Sales at Xenex. "The robot is very efficient and its speed enables it to disinfect areas and rooms quickly so they can be used throughout the entire facility, including multi-bed wards, to help reduce the risk of infection throughout the hospital."

The Xenex LightStrike Germ-Zapping Robot is designed for speed, effectiveness and ease of use, which allows hospital cleaning staff to operate the robot without disrupting hospital operations. With a four- or five-minute disinfection cycle (depending on robot model), the robot can disinfect 30-62 hospital rooms per day (according to Xenex customers), including patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas. More than 400 hospitals, Veterans Affairs, Department of Defense, skilled nursing, ambulatory surgery centers and long-term acute care facilities in the U.S., Africa, Canada and Europe use Xenex robots for room disinfection.


About Terumo Corporation
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.


Xenex Disinfection Services
Xenex's patented Full SpectrumTM pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. Xenex's mission is to save lives and reduce suffering by eliminating the deadly microorganisms that cause hospital acquired infections (HAIs). The company is backed by well-known investors that include Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures and RK Ventures. For more information, visit Xenex.com.

Back to HCB News

You Must Be Logged In To Post A Comment